Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Parasite Immunol ; 41(5): e12620, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30815888

RESUMO

AIMS: The polymorphism observed in Leishmania braziliensis is associated with different clinical forms of leishmaniasis. Neutrophils (PMNs) participate in the pathogenesis of leishmania infection, and here, we evaluate neutrophil function after infection with isolates of L. braziliensis from cutaneous leishmaniasis (CL) or disseminated leishmaniasis (DL) patients. METHODS AND RESULTS: Neutrophils from 30 healthy subjects (HS) were infected with isolates of L. (V.) braziliensis obtained from three CL and three DL patients. They were infected at the ratio of 3:1 parasites per neutrophil, and leishmania uptake was evaluated by microscopy. The neutrophil activation markers and oxidative burst by expression of dihidrorhodamine (DHR) were evaluated by flow cytometry and cytokine production by ELISA. The frequency of infected cells and the number of amastigotes were higher in neutrophils infected with CL isolates compared to DL isolates (P < 0.05). The DHR and CD66b expression after infection with DL isolate was lower than with CL isolates. There was no difference regarding chemokine production. CONCLUSION: The L. (V.) braziliensis isolates of DL induced lower respiratory burst and neutrophils activation markers compared with CL isolates which may contribute to parasite survival and dissemination in DL patients.


Assuntos
Antígenos CD/metabolismo , Moléculas de Adesão Celular/metabolismo , Leishmania braziliensis/imunologia , Leishmaniose Cutânea/imunologia , Adolescente , Adulto , Animais , Feminino , Proteínas Ligadas por GPI/metabolismo , Humanos , Leishmania braziliensis/isolamento & purificação , Leishmaniose Cutânea/parasitologia , Masculino , Ativação de Neutrófilo , Neutrófilos/imunologia , Adulto Jovem
2.
Chem Immunol Allergy ; 90: 29-44, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16210901

RESUMO

Studies have demonstrated that people living in areas endemic for helminths have a decreased reactivity to skin prick tests to aeroallergens and milder forms of asthma. Hypotheses to explain the inverse correlation between helminth infections and atopy include competition between helminth-induced polyclonal IgE and aeroallergen-specific IgE for high-affinity receptors present on mast cells, increased number of regulatory T cells, and high levels of regulatory cytokines, such as IL-10, produced during helminthic infections. Indeed, cells from asthmatic individuals infected with Schistosoma mansoni produce lower levels of IL-5 than asthmatics free of infections. In contrast, IL-10 is more readily produced by allergen-stimulated cells from asthmatics who are infected and is detected only at low levels by cells from helminth-free asthmatics. It is well known that Th2 cytokines are involved in the pathogenesis of allergies and asthma, and some studies indicate that IL-10 is the key cytokine that inhibits the Th2-inflammatory response in allergy. In this chapter we will discuss the association between S. mansoni infection, atopy and severity of asthma and possible mechanisms by which individuals living in helminth endemic areas are protected against the development of allergies.


Assuntos
Alérgenos/imunologia , Asma/complicações , Asma/imunologia , Schistosoma mansoni/imunologia , Esquistossomose/imunologia , Animais , Asma/parasitologia , Dermatite Atópica/imunologia , Dermatite Atópica/parasitologia , Humanos , Modelos Imunológicos , Esquistossomose/complicações , Esquistossomose/parasitologia
3.
Acta Trop ; 93(1): 49-56, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15589797

RESUMO

The antibody response against Leishmania (Leishmania) amazonensis crude antigen was measured through the indirect immunofluorescent assay (IFA) and the immunoenzymatic assay (ELISA) in 114 patients with cutaneous leishmaniasis (CL) in Brazil. Fifty-four patients were infected by Leishmania (Viannia) braziliensis, and 60 patients had L. (V.) guyanensis infection. Patients were comparable by age, sex, disease duration and the Montenegro skin test diameter. L. (V.) braziliensis-infected patients showed significant lower number of ulcerated lesions, greater ulcerated area and higher proportion of lymph node enlargement. Sensitivity of IFA was 79.6% (95% CI 66.1-88.9) and 71.7% (95% CI 58.4-82.2) for L. (V.) braziliensis and L. (V.) guyanensis-infected patients, respectively (P=0.324). Sensitivity of ELISA was 98.2% (95% CI 88.8-99.9) and 85.0% (95% CI 72.9-92.5) for L. (V.) braziliensis and L. (V.) guyanensis-infected patients, respectively (P=0.018). Significant differences were observed in the magnitude of the antibody response before treatment with higher levels detected in L. (V.) braziliensis-infected patients by both serologic techniques. Eighty-four patients had serologic evaluations before and 12 weeks after treatment with meglumine antimoniate, 20 mg/kg/day for 20 days. Significant lower optic density values were observed after treatment with both species independent of cure or failure. Our data showed that L. (V.) braziliensis induces a higher antibody response against L. (L.) amazonensis antigens than L. (V.) guyanensis and that down-modulation of the antibody response occurs shortly during disease evolution after treatment. Moreover the data support the use of ELISA as a better tool for detection of antibodies in CL.


Assuntos
Anticorpos Antiprotozoários/biossíntese , Leishmania braziliensis/imunologia , Leishmania guyanensis/imunologia , Leishmaniose Cutânea/imunologia , Leishmaniose Cutânea/parasitologia , Adolescente , Adulto , Animais , Anticorpos Antiprotozoários/sangue , Antígenos de Protozoários , Antiprotozoários/administração & dosagem , Antiprotozoários/uso terapêutico , Brasil , Ensaio de Imunoadsorção Enzimática , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Leishmaniose Cutânea/tratamento farmacológico , Masculino , Meglumina/administração & dosagem , Meglumina/uso terapêutico , Antimoniato de Meglumina , Compostos Organometálicos/administração & dosagem , Compostos Organometálicos/uso terapêutico , Testes Cutâneos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...